ABSTRACT
INTRODUCTION: Long-term study evidence about the BioBall® adapter system is limited, especially in highly morbid elderly patients. Thus, we analysed the long-term outcome of revision hip arthroplasty using this system in highly morbid elderly patients. MATERIALS AND METHODS: We included 19 patients undergoing revision hip arthroplasty after primary or secondary total hip arthroplasty dislocations between July 2002 and August 2004 and followed up their long-term outcome until 2015. RESULTS: The patients achieved a median of 17 points in the Merle d'Aubigné hip score in 2004 and a median of 18 points in 2011, and the 4 surviving patients in 2015 achieved 18 points. For the four 12-year survivors, the Merle d'Aubigné score was virtually stable over the complete observation period. The Harris Hip Score showed comparable results. The patients had a median Barthel index of 90 in 2004 and 100 in 2011, and the 4 survivors in 2015 had Barthel indices of 65, 95, 100, and 100, respectively, in 2015. CONCLUSIONS: In multimorbid patients, using the BioBall® adapter system for total hip arthroplasty, revision due to dislocation results in good long-term outcome without impairment of quality of life. TRANSLATIONAL POTENTIAL: Our study provides long-term evidence in a vulnerable patient population. It shows how the therapeutic concept of revision hip replacement with an adapter device translates into long-term outcome and quality of life in these patients. Thus, it adds important information for evaluation of therapeutic options in this field.
